Vimarsana
Biggest News Aggregation in the World

Patent Interference News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Patent Interference. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Patent Interference Today - Breaking & Trending Today

Specialist Chapter: Trends and Strategies in Global Pharma and Biotech Patent Litigation - Vimarsana News

Specialist Chapter: Trends and Strategies in Global Pharma and Biotech Patent Litigation

IAM is a unique and timely intelligence service that treats IP as a business asset and tool rather than simply as a legal right, informing boardrooms worldwide.

Intellectual Property Law Notable Cases to Watch for 2023 - Vimarsana News

Intellectual Property Law Notable Cases to Watch for 2023

U.S. courts will have a full docket of challenging IP cases throughout 2023. Andy Warhol Found. for Visual Arts, Inc. v. Goldsmith, Amgen Inc. v. Sanofi, Interactive Wearables, LLC v. Polar Electro Oy et al., VIP Prods. LLC v. Jack Daniel's Props., Nike, Inc. v. StockX LLC.

Intellectual Property Law: Looking Forward to 2023 | Cadwalader, Wickersham & Taft LLP - Vimarsana News

Intellectual Property Law: Looking Forward to 2023 | Cadwalader, Wickersham & Taft LLP

With the continuing advancements of cutting-edge technologies — such as genome editing (CRISPR) and Non-Fungible Tokens (NFTs) — U.S. courts will have a full docket of challenging IP...

Amgen Inc. v. Sanofi: Does the Supreme Court's Call for the Solicitor General's Views Signal an Intention to Resolve Important Enablement Questions for Genus Claims? - Vimarsana News

Amgen Inc. v. Sanofi: Does the Supreme Court's Call for the Solicitor General's Views Signal an Intention to Resolve Important Enablement Questions for Genus Claims?

Is the genus claim dead, or has its demise been greatly exaggerated? We may soon have the Supreme Court’s answer. On April 18, following eight years…

Antibody Combinations in Immunotherapy Offer New Opportunities for Innovators to Strengthen IP Protections - Vimarsana News

Antibody Combinations in Immunotherapy Offer New Opportunities for Innovators to Strengthen IP Protections

Companies have been exploring the potential to use combinations of various checkpoint inhibitors to enhance the treatment of patients with various…